Edmund Torkelson, DO
Internal Medicine · Beaverton, ORNPI 1083701833
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 273 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,541, 2.6 times the $595 reported in 2021. Among internal medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 273 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$655
- Lilly USA, LLC$524
- Amgen$502
- AstraZeneca$402
- Viiv Healthcare Company$382
- Pfizer$324
- plus $3K from 33 others
What the payments were for
- Food & beverage$5,701100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $655 |
| Lilly USA, LLC | 22 | $524 |
| Amgen | 22 | $502 |
| AstraZeneca | 25 | $402 |
| Viiv Healthcare Company | 17 | $382 |
| Pfizer | 17 | $324 |
| GSK | 11 | $243 |
| Merck | 11 | $237 |
| Novo Nordisk | 7 | $229 |
| Bayer | 5 | $224 |
| Novartis | 11 | $218 |
| Gilead | 10 | $191 |
| Vanda Pharmaceuticals Inc. | 7 | $189 |
| Boehringer Ingelheim | 8 | $181 |
| Johnson & Johnson | 9 | $171 |
| E.r. Squibb & Sons, L.L.C. | 5 | $129 |
| Exact Sciences | 6 | $120 |
| Axsome Therapeutics, Inc. | 3 | $78 |
| Boston Scientific | 3 | $76 |
| Lundbeck LLC | 2 | $63 |
| Dexcom, Inc. | 3 | $57 |
| Abbott | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Seqirus USA Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $31 |
| Amneal Pharmaceuticals LLC | 1 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Medtronic | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Bioventus LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Tanabe Pharma America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,701 in reported general payments places this provider in the 95th percentile of 1,363 internal medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 39 | $88,670 |
| EliquisApixaban | 67 | $73,154 |
| JardianceEmpagliflozin | 41 | $58,648 |
| OzempicSemaglutide | 21 | $22,845 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,436 |
| NexiumEsomeprazole Magnesium | 13 | $6,967 |
| EntrestoSacubitril/Valsartan | 13 | $6,860 |
| ProtonixPantoprazole Sodium | 13 | $5,497 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,803 |
| Atorvastatin Calcium | 234 | $3,424 |
| Celecoxib | 80 | $2,883 |
| Losartan Potassium | 207 | $2,842 |
| Levothyroxine Sodium | 174 | $2,813 |
| Ipratropium Bromide | 94 | $2,613 |
| Arnuity ElliptaFluticasone Furoate | 12 | $2,348 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Protonix | $324 | $78,65180 claims |
| Boehringer IngelheimJardiance | $181 | $58,64841 claims |
| Novo NordiskOzempic | $229 | $22,84521 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $243 | $18,58742 claims |
| AstraZenecaNexium | $402 | $6,96713 claims |
| NovartisEntresto | $218 | $6,86013 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $31 | $2,813174 claims |
| AbbVieSynthroid | $655 | $1,31521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,363 internal medicine providers in Oregon.
Other internal medicine in Beaverton
- Chad PfeferBeaverton$639K
- Thomas GilbertsBeaverton$2K
- David LarsonBeaverton$2K
- Pranav ChandrashekarPortland$81K
- Jonathan EdmistonBend$68K
- Jessica CastlePortland$66K
- Ellen Schiaffino PurvisGresham$66K
- Steven ShawWhite City$58K
- Stephen SpurgeonPortland$42K
- Jane BabiarzPortland$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.